Disease-A-Month
Volume 54, Issue 12 , Pages 780-786 , December 2008

Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections

References 

  1. Finch R. Skin and soft tissue infections. Lancet. 1988;1:164–168
  2. Charlebois ED, Perdreau-Reminton F, Kreiswirth B, et al. Origins of community strains of methicillin-resistant Staphyloccus aureus.. Clin Infect Dis. 2004;39:47–54
  3. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666–674
  4. Garnier F, Tristan A, Francois B, et al. Pneumonia and new methicillin-resistant Staphylococcus aureus clone. Emerg Infect Dis. 2006;12:498–500
  5. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352:1436–1444
  6. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison: Mississippi, 2000. MMWR Morb Mortal Wkly Rep. 2001;50:919–922
  7. Miller LG, Perdreau-Remington F, Reig G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352:1445–1453
  8. Kline MD, Humphrey BS, Wang YF, et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft tissue infections. Ann Intern Med. 2006;144:309–317
  9. Kazakova SV, Hageman JC, Matava M, et al. A clone of methicillin-resistant Staphylococcus aureus among Professional Football Players. N Engl J Med. 2005;352:468–475
  10. Petrucelli B, Rubertone MV, Brundage JF, et al. Cellulitis and abscess, Active Components, US Armed Forces, 2002-2005. Medical Surveillance Monthly Report US Army Center for Health Promotion and Preventative Medicine. 2006;12:2–8
  11. McDougal LK, Steward CD, Killgore GE, et al. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States; establishing a national database. J Clin Microbiol. 2003;41:5113–5120
  12. Yamasaki O, Kaneko J, Morizane S, et al. The association between Staphylococcus aureus strains carrying Panton-Valentine leukocidin genes and the development of deep-seated follicular infection. Clin Infect Dis. 2005;40:381–385
  13. Voyich JM, Otto M, Mathema B, et al. Is Panton-Valentine Leukocidin the major virulence determinant in community-associated methicillin resistant Staphylococcus aureus disease?. J Infect Dis. 2006;194:1761–1770
  14. Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5:751–762
  15. Ellis MW, Hospenthal DR, Dooley DP, et al. Natural history of community-acquired methicillin-resistant Staphyloccus aureus colonization and infection in soldiers. Clin Infect Dis. 2004;39:971–979
  16. von Eiff C, Becker K, Machka K, et al. Nasal carriage as a source of Staphylococcus aureus bacteremia (Study Group). N Engl J Med. 2001;344:11–16
  17. Perl TM, Cullen JJ, Wenzel RP. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002;346:1871–1877
  18. Ellis MW, Griffith ME, Dooley DP, et al. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin resistant staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Antimicrob Agents Chemother. 2007;51:3591–3598
  19. Miller LG, Diep AD. Colonization, fomites and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2008;46:752–760
  20. Campbell KM, Vaughn AF, Russell KL, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California in 2002. J Clin Microbiol. 2004;42(9):4050–4053
  21. Turabelidze G, Lin M, Wolkoff B, et al. Personal hygiene and methicillin-resistant Staphylococcus aureus infection. Emerg Infect Dis. 2004;10:941–944
  22. Shastry L, Rahimian J, Lascher S. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections in men who have sex with men in New York City. Arch Intern Med. 2007;167:854–857
  23. Minnesota Department of Health. Community-associated methicillin resistant Staphylococcus aureus in Minnesota. Minnesota Department of Heath Disease Control Newsletter. 2004;32:61–72
  24. Grayson LM. The treatment triangle for Staphylococcal infections. N Engl J Med. 2006;355:724–726
  25. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus.. Pediatr Infect Dis J. 2004;23:123–127
  26. Moellering RC. A 39-year-old man with skin infection. J Am Med Assoc. 2008;299:79–87
  27. Weigelt J, Kaafarani HM, Itani KM, et al. Linezolid eradicates MRSA better than vancomycin from surgical-site infections. Am J Surg. 2004;188:760–766

 Disclaimer: The opinions and assertions contained herein are those of the authors and are not to be construed as official or as reflecting the views of the Department of Defense, the Department of the Navy, or the naval services at large.

PII: S0011-5029(08)00124-7

doi: 10.1016/j.disamonth.2008.09.010

Disease-A-Month
Volume 54, Issue 12 , Pages 780-786 , December 2008

Article Tools